H.R. 5020
Referred to CommitteeSynthetic Drug Awareness Act of 2016
Introduced 4/21/2016•114th Congress•House
Latest Action
Referred to the Subcommittee on Health.
4/22/2016 • House
Summary
Synthetic Drug Awareness Act of 2016
This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").Introduced in House • 4/21/2016
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Child healthCongressional oversightDrug trafficking and controlled substancesDrug, alcohol, tobacco use
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (7)
Party Breakdown
2
Democrats
5
Republicans
0
Independents
Sponsor
R[
Cosponsors (6)
R[
R[
R[
R[
R[
R[
Bill Journey
Originated in the House
Introduced
April 21, 2016
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House4/21/2016